Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00974831 · ClinicalTrials.gov registry record · Phase 2
Glucose Tolerance in Healthy Overweight Adults
A Phase 2 study of Overweight, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00974831 is a Phase 2 study of Overweight that has completed, run by Abbott Nutrition. The registered enrollment target is 24 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00974831, a Phase 2 study of Overweight, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to compare the postprandial glycemic response of healthy overweight adults after consuming an amino acid drink mix versus a control drink.
Conditions Studied
Interventions
- OTHER Amino Acid Drink Mixture
- OTHER Glucose drink
Study Locations (1)
Texas
- University of Texas - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00974831
The ClinicalTrials.gov registry entry for NCT00974831 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which Amino Acid Drink Mixture is the first listed.
NCT00974831 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00974831 about?
NCT00974831 is a clinical study titled "Glucose Tolerance in Healthy Overweight Adults". The primary objective is to compare the postprandial glycemic response of healthy overweight adults after consuming an amino acid drink mix versus a control drink.
What is the current status of trial NCT00974831?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2009-07. Estimated completion is 2009-10.
What conditions does trial NCT00974831 study?
This clinical trial studies the following conditions: Overweight.
What interventions are being tested in trial NCT00974831?
The interventions under investigation include: Amino Acid Drink Mixture (OTHER), Glucose drink (OTHER).
Who is sponsoring clinical trial NCT00974831?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00974831 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity
RECRUITING · Phase 2
-
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
RECRUITING · Phase 2
-
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
RECRUITING · Phase 2
-
Semaglutide for Post-Smoking Cessation Weight Management
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.